UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Cancer treatment reviews, 2019-06, Vol.76, p.57-67

2019

Volltextzugriff (PDF)

Prediction of an Imminent Fracture After an Index Fracture – Models Derived From the Frisbee Cohort

Journal of bone and mineral research, 2022-01, Vol.37 (1), p.59-67

2022

Volltextzugriff (PDF)

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Calcified Tissue International, 2016, Vol.98 (1), p.1-17

2016

Volltextzugriff (PDF)

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

Journal of internal medicine, 2023-03, Vol.293 (3), p.309-328

2023

Volltextzugriff (PDF)

Postfracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT

Journal of bone and mineral research, 2020-04, Vol.35 (4), p.827-828

2020

Volltextzugriff (PDF)

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

The journal of clinical endocrinology and metabolism, 2022-04, Vol.107 (5), p.1441-1460

2022

Volltextzugriff (PDF)

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5132-5139

2010

Volltextzugriff (PDF)

Increased fracture rate in women with breast cancer: a review of the hidden risk

BMC cancer, 2011-08, Vol.11 (1), p.384-384, Article 384

Body, Jean-Jacques

2011

Volltextzugriff (PDF)

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1564-1571

2009

Volltextzugriff (PDF)

Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohort

International journal of clinical practice (Esher), 2019-05, Vol.73 (5), p.e13347-n/a

2019

Volltextzugriff (PDF)

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

Supportive care in cancer, 2019-02, Vol.27 (2), p.383-394

2019

Volltextzugriff (PDF)

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.908727-908727

2022

Volltextzugriff (PDF)

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid

Cancer, 2013-02, Vol.119 (4), p.832-838

2013

Volltextzugriff (PDF)

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

Journal of bone oncology, 2021-06, Vol.28, p.100355, Article 100355

2021

Volltextzugriff (PDF)

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure

Journal of bone and mineral research, 2010-03, Vol.25 (3), p.440-446

2010

Volltextzugriff (PDF)

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4431-4437

2007

Volltextzugriff (PDF)

Patient preferences for treatments to delay bone metastases

The Prostate, 2014-11, Vol.74 (15), p.1488-1497

2014

Volltextzugriff (PDF)

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort

JBMR plus, 2021-09, Vol.5 (9), p.e10532-n/a

2021

Volltextzugriff (PDF)

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

Journal of bone oncology, 2019-02, Vol.14, p.100212, Article 100212

2019

Volltextzugriff (PDF)

Bisphosphonates Induce Breast Cancer Cell Death In Vitro

Journal of bone and mineral research, 2000-11, Vol.15 (11), p.2211-2221

2000

Volltextzugriff (PDF)

A Phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

Cancer, 2003-02, Vol.97 (S3), p.887-892

2003

Volltextzugriff (PDF)

Fibroblast growth factor 23 and its role in phosphate homeostasis

European journal of endocrinology, 2010-01, Vol.162 (1), p.1-10

2010

Volltextzugriff (PDF)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

BMC urology, 2018-09, Vol.18 (1), p.81-11, Article 81

2018

Volltextzugriff (PDF)

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

The journal of clinical endocrinology and metabolism, 2021-01, Vol.106 (1), p.264-281

2021

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(165)
Science & Technology
(165)
Humans
(152)
Female
(98)
Oncology
(83)
Biological And Medical Sciences
(67)
Medical Sciences
(61)
Bone Neoplasms - Secondary
(60)
Middle Aged
(59)
Endocrinology & Metabolism
(52)
Male
(52)
Aged
(50)
Diphosphonates - Therapeutic Use
(50)
Adult
(40)
Bone Neoplasms - Drug Therapy
(40)
Breast Neoplasms - Pathology
(40)
Osteoporosis
(39)
Bone Metastases
(37)
Breast Cancer
(37)
Bone Density Conservation Agents - Therapeutic Use
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Prediction of an Imminent Fracture After an Index Fracture – Models Derived From the Frisbee Cohort

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

Postfracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Increased fracture rate in women with breast cancer: a review of the hidden risk

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohort

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Patient preferences for treatments to delay bone metastases

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

Bisphosphonates Induce Breast Cancer Cell Death In Vitro

A Phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

Fibroblast growth factor 23 and its role in phosphate homeostasis

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

Suchergebnisse filtern